A comparative study of hypolipidemic effect of atorvastatin and Coriandrum sativum in triton-induced hyperlipidemic albino rat model

Introduction: Hyperlipidemia is a main factor responsible for coronary artery disease. Atorvastatin, commonly used competitive inhibitor of HMG-Co-A reductase, is known to reduce the levels of LDL, triglyceride and increase the levels of HDL. Coriandrum sativum (Coriander) belongs to the Apiaceae fa...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of clinical biochemistry 2016-12, Vol.31 (S1), p.S33
Main Authors: Acharya, Swathi, Puneeth, A
Format: Article
Language:English
Subjects:
Antilipemic agents
Blood cholesterol
Comparative analysis
Coronary heart disease
Hypercholesterolemia
Low density lipoproteins
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: Hyperlipidemia is a main factor responsible for coronary artery disease. Atorvastatin, commonly used competitive inhibitor of HMG-Co-A reductase, is known to reduce the levels of LDL, triglyceride and increase the levels of HDL. Coriandrum sativum (Coriander) belongs to the Apiaceae family, has hypolipidemic, antidiabetic, anti-oxidant properties. Triton WR1339 has been used by several studies to induce hypercholesterolemia in animals which acts on both synthesis and excretory phase. Aim and Objectives: To compare the hypolipidemic effect of Coriandrum sativum and Atorvastatin in Triton-induced hyperlipidemic rats. Materials and Methods: Following approval from the Institutional Animal Ethics committee, 36 Wistar albino rats were divided into 6 groups of 6 animals each. Triton 200mg IP was administered to all the groups except Group 1 (control). Group 3 and 4 received Coriander extract 300mg/kg and Atorvastatin 80mg/kg orally along with Triton. Group 5 and 6 received Coriander extract and Atorvastatin respectively 22 hours later. Lipid profile was estimated 24 hours before, 24 and 48 hours after administering Triton. Results: In the synthesis phase, there is a statistically significant increase in the lipid levels in Groups 2, 5, 6 compared to Groups 3, 4 indicating hypolipidemic effects of both Coriander extract and Atorvastatin. In the excretory phase, all groups have shown decrease in lipid levels but decrease in total cholesterol level in Group 5 compared to Group 3 was significant. Conclusion: Atorvastatin and Coriander extract both have effect on the lipid levels in synthesis and excretory phase. Even though Coriander cannot replace Atorvastatin in management of hyperlipidemia, it can be used as an adjuvant to atorvastatin so as to reduce the cost effects and adverse reactions caused by allopathic medicines. Keywords: Hyperlipidemia, Atorvastatin, Coriander sativum, Triton
ISSN:0970-1915